Dr Stephen Matthew Becker, MD | |
220 Associates Blvd, Alcoa, TN 37701-1943 | |
(865) 238-6400 | |
(865) 238-6404 |
Full Name | Dr Stephen Matthew Becker |
---|---|
Gender | Male |
Speciality | Plastic And Reconstructive Surgery |
Experience | 23 Years |
Location | 220 Associates Blvd, Alcoa, Tennessee |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1164628145 | NPI | - | NPPES |
1514107 | Medicaid | TN |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208200000X | Plastic Surgery | 45217 (Tennessee) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Blount Memorial Hospital | Maryville, TN | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Blount Memorial Physician Group Inc | 6406844174 | 242 |
News Archive
ICF International, a leading provider of consulting services and technology solutions to government and commercial clients, has been awarded a new $11.7 million contract by the U.S. Department of Health and Human Services (HHS), Centers for Disease Control and Prevention (CDC). The contract has a term of three years. The contract is awarded under a CDC National Center for Birth Defects and Developmental Disabilities ID/IQ task order.
Soligenix, Inc., a clinical stage biopharmaceutical company, announced today that its SGX942 development program for the treatment of oral mucositis as a result of radiation and/or chemotherapy treatment in head and neck cancer patients has received "Fast Track" designation from the US Food and Drug Administration.
Health care has much to learn from innovative high-tech companies, but not in the way most people think, according to a Perspective published today in the New England Journal of Medicine and authored by innovation experts from the Perelman School of Medicine and the Wharton School at the University of Pennsylvania. Innovation, they say, can most effectively achieve meaningful outcomes by testing many new ideas quickly, cheaply, and contextually.
Each year, approximately 2.4 million people - more than half under age 6 - swallow or have contact with a poisonous substance..
› Verified 1 days ago
Entity Name | Blount Memorial Physician Group Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1699710194 PECOS PAC ID: 6406844174 Enrollment ID: O20040503000547 |
News Archive
ICF International, a leading provider of consulting services and technology solutions to government and commercial clients, has been awarded a new $11.7 million contract by the U.S. Department of Health and Human Services (HHS), Centers for Disease Control and Prevention (CDC). The contract has a term of three years. The contract is awarded under a CDC National Center for Birth Defects and Developmental Disabilities ID/IQ task order.
Soligenix, Inc., a clinical stage biopharmaceutical company, announced today that its SGX942 development program for the treatment of oral mucositis as a result of radiation and/or chemotherapy treatment in head and neck cancer patients has received "Fast Track" designation from the US Food and Drug Administration.
Health care has much to learn from innovative high-tech companies, but not in the way most people think, according to a Perspective published today in the New England Journal of Medicine and authored by innovation experts from the Perelman School of Medicine and the Wharton School at the University of Pennsylvania. Innovation, they say, can most effectively achieve meaningful outcomes by testing many new ideas quickly, cheaply, and contextually.
Each year, approximately 2.4 million people - more than half under age 6 - swallow or have contact with a poisonous substance..
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Stephen Matthew Becker, MD 103 W Broadway Ave, Maryville, TN 37801-4703 Ph: (865) 273-1752 | Dr Stephen Matthew Becker, MD 220 Associates Blvd, Alcoa, TN 37701-1943 Ph: (865) 238-6400 |
News Archive
ICF International, a leading provider of consulting services and technology solutions to government and commercial clients, has been awarded a new $11.7 million contract by the U.S. Department of Health and Human Services (HHS), Centers for Disease Control and Prevention (CDC). The contract has a term of three years. The contract is awarded under a CDC National Center for Birth Defects and Developmental Disabilities ID/IQ task order.
Soligenix, Inc., a clinical stage biopharmaceutical company, announced today that its SGX942 development program for the treatment of oral mucositis as a result of radiation and/or chemotherapy treatment in head and neck cancer patients has received "Fast Track" designation from the US Food and Drug Administration.
Health care has much to learn from innovative high-tech companies, but not in the way most people think, according to a Perspective published today in the New England Journal of Medicine and authored by innovation experts from the Perelman School of Medicine and the Wharton School at the University of Pennsylvania. Innovation, they say, can most effectively achieve meaningful outcomes by testing many new ideas quickly, cheaply, and contextually.
Each year, approximately 2.4 million people - more than half under age 6 - swallow or have contact with a poisonous substance..
› Verified 1 days ago